A triple-action cancer jab blocked a crucial protein that helps cancers grow and stopped a second pathway that tumour cells ...
Improved radiographic progression-free survival (rPFS) regardless of disease volume or metastatic presentation achieved with ...
A previous trial involving patients with metastatic prostate cancer that was resistant to androgen pathway modulation (formerly referred to as castration-resistant) showed that adding talazoparib ...
Doctors hail cancer injection that can destroy entire tumors - The results of the trial will be presented during the American ...
(NYSE: PFE) today announced detailed results from the pivotal Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...
Regulated cell death (RCD) comprises a diverse and expanding set of molecularly defined processes, such as apoptosis, necroptosis, ferroptosis, and ...
Absence of a scalp-specific cancer excess challenges the UV-exposure hypothesis and supports maintaining standard, individualized skin cancer risk assessment rather than AA-specific screening ...
The U.S. Food and Drug Administration today issued a draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs. “This draft guidance not only ...
The first randomized trial to evaluate whether a multicancer early detection test using a blood sample could result in diagnosis at earlier stages yielded mixed results.The NHS-Galleri trial did not ...
The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.
Most significant change years in pancreatic cancer drug demand drives Mayo Clinic and others to expand access and patient education on daraxonrasib.
Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results